Skip to main content

Table 2 Case summary of complete remission (CR) of advanced hepatocellular carcinoma achieved by sorafenib treatment

From: Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib

Case No. Age (year), gender Metastatic sites Initial dose CR time (month) CR duration (month) Publication time Journal Reference Note
1 78, male Lung 400 5 6 17/10/08 Journal of Hematology & Oncology So et al. [4] First case of CR
2 54, male Lung 400 18 Unknown 1/9/09 American Journal of Transplantation Yeganeh et al. [5] Solitary pulmonary metastasis post liver transplantation
3 59, male Portal vein 400 6 16 14/3/10 Liver International ISSN Irtan et al. [6] Two cases reported in the same report; CR achieved by surgical resection in the descent stage following sorafenib treatment.
4 57, male Portal vein 400 6 12 14/3/10 Liver International ISSN Irtan et al. [6]
5 74, male Portal vein 200 8 16 23/3/10 Targeted Oncology Wang et al. [7] Initial dose at a low level
6 67, male Portal lymph node 400 6 6 31/8/10 Medical Oncology Chelis et al. [8] HIV-hepatitis B virus (HBV) co-infected with advanced hepatocellular carcinoma
7 56, male Thoracic diaphragm 400 6 6 20/4/11 Journal of Clinical Oncology Curtit et al. [9] CR achieved by surgical resection in the descent stage following sorafenib treatment.
8 84, male Portal vein 400 6 6 11/4/11 BMC Gastroenterology Sacco et al. [10] First case of CR in hepatitis C patients in older people
9 76, female Lung 200 4 8 22/12/11 Oncology Inuzuka et al. [11] First female case
10 60, male Portal lymph node 400 11 days 12 24/7/12 Oncology Mizukami et al. [12] Shortest time to achieve CR
11 52, male Lung 400 6 42 10/10/12 Journal of Gastrointestinal Cancer Lulla et al. [13] Longest duration of CR
12 66, male Portal vein 400 6 8 15/2/13 World Journal of Gastrointestinal Oncology Kim et al. [14]